David Zemánek

2023 ESC Guidelines for the management of cardiomyopathies

Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno et al. · European Heart Journal · 2023 · 2.4K citations · Full text

Medicine, Cardiology, Internal Medicine +12

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest

Jan Bělohlávek, Jana Šmalcová, Daniel Rob et al. · JAMA · 2022 · 678 citations · Full text

Medicine, Emergency Medicine, Cardiothoracic Surgery +16

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation

Pavel Osmančík, Dalibor Heřman, Petr Neužil et al. · Journal of the American College of Cardiology · 2020 · 614 citations

Medicine, Cardiology, Internal Medicine +13

4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation

Pavel Osmančík, Dalibor Heřman, Petr Neužil et al. · Journal of the American College of Cardiology · 2021 · 274 citations

Medicine, Cardiology, Perioperative Medicine +12